A Comparison of Seroquel vs. Risperidone in Schizophrenia

Phase 4

Completed

• Conditions: Schizophrenia

• Registration Number: NCT00034905
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-07
• Study First Submitted: 2002-05-02
• Study First Submitted QC: 2002-05-02
• Study First Posted: 2002-05-03
• Primary Completion: 2002-09
• Study Completion: 2002-09
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-03
• Last Update Posted: 2013-01-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified